BENEVENTO, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 1.388
EU - Europa 782
AS - Asia 470
AF - Africa 81
SA - Sud America 5
Totale 2.726
Nazione #
US - Stati Uniti d'America 1.384
CN - Cina 163
IT - Italia 158
GB - Regno Unito 154
SG - Singapore 138
DE - Germania 124
SE - Svezia 122
VN - Vietnam 101
IE - Irlanda 46
RU - Federazione Russa 45
IN - India 43
TG - Togo 42
CH - Svizzera 22
FR - Francia 21
BG - Bulgaria 16
CI - Costa d'Avorio 16
FI - Finlandia 15
ZA - Sudafrica 12
BE - Belgio 11
EE - Estonia 11
JO - Giordania 11
HR - Croazia 8
NG - Nigeria 8
UA - Ucraina 8
MK - Macedonia 6
ID - Indonesia 5
CL - Cile 4
NL - Olanda 4
AT - Austria 3
CA - Canada 3
LT - Lituania 3
UZ - Uzbekistan 3
ES - Italia 2
AR - Argentina 1
DK - Danimarca 1
EG - Egitto 1
GR - Grecia 1
HK - Hong Kong 1
IR - Iran 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MU - Mauritius 1
MX - Messico 1
SA - Arabia Saudita 1
SC - Seychelles 1
TW - Taiwan 1
Totale 2.726
Città #
Fairfield 173
Chandler 168
Ashburn 143
Southend 142
Singapore 112
Dong Ket 100
Woodbridge 88
Seattle 75
Santa Clara 66
Houston 60
Wilmington 56
Bologna 53
Boardman 49
Dublin 46
Princeton 43
Lomé 42
Cambridge 41
Ann Arbor 39
Bern 21
New York 19
Abidjan 16
Sofia 16
Redmond 14
Westminster 14
Beijing 13
Turin 13
Falkenstein 12
Helsinki 12
Nanjing 12
Washington 12
Amman 11
Brussels 11
Shenyang 11
Berlin 10
Abeokuta 8
Bremen 8
Milan 7
Nuremberg 7
Padova 7
Saint Petersburg 7
Des Moines 6
Florence 6
Fort Worth 6
Guangzhou 6
Jinan 6
Shanghai 6
Skopje 6
Jakarta 5
Los Angeles 5
San Diego 5
Zhengzhou 5
Mountain View 4
Redwood City 4
Rome 4
Taiyuan 4
Wuhan 4
Amsterdam 3
Borgo Tossignano 3
Chongqing 3
Frankfurt am Main 3
Fremont 3
Haikou 3
Lappeenranta 3
London 3
Medford 3
Nanchang 3
Napoli 3
Norwalk 3
Ancona 2
Bühl 2
Changsha 2
Chengdu 2
Dearborn 2
Esslingen am Neckar 2
Ferrara 2
Hangzhou 2
Hebei 2
Hounslow 2
Kuban 2
Leawood 2
Lucca 2
Lübeck 2
Mirano 2
Monmouth Junction 2
Moscow 2
Ningbo 2
Olalla 2
Ottawa 2
Paris 2
Shenzhen 2
Shijiazhuang 2
Acton 1
Alfonsine 1
Anyang 1
Augusta 1
Baoding 1
Bari 1
Bellinzago Novarese 1
Cairo 1
Castelnuovo Rangone 1
Totale 1.930
Nome #
Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: experience of the Bologna Liver Oncology Group. 191
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 163
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study 150
Surveillance for Hepatocellular Carcinoma Also Improves Survival of Incidentally Detected Intrahepatic Cholangiocarcinoma Arisen in Liver Cirrhosis 142
Inter-operator variability and source of errors in tumour response assessment for hepatocellular carcinoma treated with sorafenib 129
MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma 127
An update of treatments of hepatocellular carcinoma in patients refractory to sorafenib 125
Systemic treatments for hepatocellular carcinoma: challenges and future perspectives 117
null 117
Pattern of macrovascular invasion in hepatocellular carcinoma 114
Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure 110
Anticoagulation in Cirrhotic Portal Vein Thrombosis: No Harm, but Survival Benefit Still Unclear 110
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 98
Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: Correlation with MGMT promoter methylation status 92
Immunotherapy for hepatocellular carcinoma: A review of potential new drugs based on ongoing clinical studies as of 2019 88
Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma (Targeted Oncology, (2020), 15, 6, (773-785), 10.1007/s11523-020-00757-3) 83
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 82
null 77
SAT-453-Effects of sorafenib on pancreatic volume and their clinical implications in patients with hepatocellular carcinoma 74
Experience with regorafenib in the treatment of hepatocellular carcinoma 74
Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma 71
Long-lasting remission in a metastatic hepatocellular carcinoma patient after combined regorafenib therapy and surgery 69
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 66
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 58
null 56
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 45
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival 43
Oral oxycodone/naloxone for pain control in cirrhosis: Observational study in patients with symptomatic metastatic hepatocellular carcinoma 43
An update on atezolizumab for hepatocellular carcinoma 39
Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients 38
Regorafenib Combined with Other Systemic Therapies: Exploring Promising Therapeutic Combinations in HCC 30
Hierarchically Positioning Laparoscopic Microwave Ablation in the Therapeutic Span of Early Hepatocellular Carcinoma: A Real-Life Comparative Analysis 4
Totale 2.825
Categoria #
all - tutte 9.669
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.669


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202061 0 0 0 0 0 0 0 0 0 36 12 13
2020/2021387 40 21 4 6 50 40 15 25 44 19 20 103
2021/2022507 52 7 15 21 46 32 9 33 19 31 178 64
2022/2023625 46 90 30 82 47 49 36 36 117 14 35 43
2023/2024291 16 50 29 18 41 64 10 19 21 11 5 7
2024/2025495 41 76 71 63 91 35 75 30 12 1 0 0
Totale 2.825